Literature DB >> 9685270

How can treatment of systemic sclerosis be improved?. By setting up a national database of all cases and entering patients into trials. UK Scleroderma Study Group.

.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9685270      PMCID： PMC1113627     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

Authors:  C P Denton; J B Cailes; G D Phillips; A U Wells; C M Black; R M Bois
Journal:  Br J Rheumatol       Date:  1997-02

Review 2.  Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy.

Authors: 
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

3.  Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation.

Authors:  A Tyndall; C Black; J Finke; J Winkler; R Mertlesmann; H H Peter; A Gratwohl
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

4.  The management of systemic sclerosis.

Authors:  C M Black; C P Denton
Journal:  Br J Rheumatol       Date:  1995-01

5.  Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.

Authors:  M Kuwana; J Kaburaki; Y Okano; T Tojo; M Homma
Journal:  Arthritis Rheum       Date:  1994-01

6.  Mortality from scleroderma in England and Wales 1968-1985.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103
  6 in total
  1 in total

Review 1.  Novel therapeutic strategies in scleroderma.

Authors:  C P Denton; C M Black
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.